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In spite of numerous vaccines and different vaccination schedules used in the control of 
Newcastle disease (ND), prevention and control remain a challenge. This study evaluated three 
different ND vaccines. A total of one hundred and twenty, day-old brown pullets obtained from a 
commercial hatchery in Ibadan, Nigeria were used for the experiment. The birds were randomly 
assigned into 4 groups in which groups A, B and C were vaccinated on days 1, 21 and 42 of age, 
while group D served as unvaccinated group (control). Hitchner B1 (HB1), Clone-30 and F-
Strains were used as the primers for the 3 vaccinated groups respectively. Blood samples were 
collected from all birds in each group on vaccination day and assayed for NDV antibody by 
Haemagglutination-inhibition (HI) test. Twenty five chickens from each group were challenged 
with virulent Newcastle disease virus (Kudu 113 strain) at 3
rd
 week after the last vaccination. 
The mean antibody titres of the chickens from the vaccinated groups at 3
rd
 week post primary 
vaccination showed no significant difference. However, a significant difference existed 




 weeks of age. A 
good immune response and clinical resistance were observed in group of chickens vaccinated 
with Hitchner B1 and Clone-30 as primers than those vaccinated using F-strain. Therefore, 
Hitchner B1 or Clone-30 is better primer for vaccinating chickens against Newcastle disease. 
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INTRODUCTION 
Newcastle disease is a highly contagious, 
viral disease of domestic poultry and wild 
birds, characterised by gastro-intestinal, 
respiratory and nervous signs (Seal et al., 
2000; Alexander, 2003). Newcastle disease 
is one of the most important viral diseases of 
poultry in the world. It occurs in most 
countries and has devastating effect on 
commercial poultry production. It is 
generally considered that the first outbreaks 
of velogenic Newcastle disease (vND) 
occurred in 1926, in Java, Indonesia
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(Kraneveld, 1926), and in Newcastle-upon-
Tyne, England (Doyle, 1927). The disease is 
caused by NDV which is an enveloped virus 
belonging to the family paramyxoviridae 
with a negative-sense, single-stranded, non-
segmented RNA genome (Aldous and 
Alexander, 2001). Newcastle disease is also 
considered as one of the major threat to 
poultry production in Nigeria, because of its 
high morbidity and mortality rates. The 
disease also causes reduction in productivity 
leading to economic losses every year. The 
disease was first reported in 1953 in Nigeria 
(Hill et al., 1953; Okeke and Lamorde, 
1988). 
The disease is kept under control by 
vaccination and other preventive measures. 
Currently practiced vaccination programme 
against ND includes administration of two 
types of live vaccines of either lentogenic 
(B1, F, Clone-30, LaSota strain) or 
mesogenic (Komarov strain) and inactivated 
vaccines. Despite vaccination outbreak of 
ND are often reported in both vaccinated 
and unvaccinated flocks (Halle et al., 1999; 
Sa’idu et al., 2006a; Sa’idu and Abdu, 2008; 
Musa et al., 2010; Aliyu et al., 2015). 
Consequently, this may be due to vaccine 
failure. 
In Nigeria poultry farmers have been using 
various imported and local ND vaccines 
following either same or different 
vaccination schedules. These vaccines are 
assumed to be highly effective against ND, 
although there is paucity of information on 
the immune response of birds to these 
vaccines. However, various scientists and 
field Veterinarians in the country find it 
difficult to determine the factors responsible 
for these sporadic outbreaks of ND in 
vaccinated flocks. Therefore, the present 
study was undertaken to compare the 
antibody titres of chickens vaccinated with 
three different imported ND vaccines of 
lentogenic strain used as primers followed 
by lentogenic and mesogenic strains and 
also evaluate the efficacy of these vaccines 
following challenge with virulent NDV 
Kudu 113 strain. 
 
MATERIALS AND METHODS 
A total of 120 apparently healthy ISA brown 
day-old pullets were purchased from Zartech 
hatchery, Ibadan and conveyed to the 
Poultry Research Pens of the Veterinary 
Teaching Hospital, Ahmadu Bello 
University, (ABUVTH) Zaria. The chicks 
were fed with commercial chick mash 
(Feedtech) and water ad libitum. The chicks 
were divided into 4 groups (groups A, B, 
and C, received primers vaccines, Hitchner 
B1, Clone-30 and F-strain respectively, 
while group D was unvaccinated control). 
They were housed in separate pens and 
attended to by separate care taker. 
 
Newcastle Disease Vaccine 
Lyophilized ND vaccines baby chick 
ranikhet disease vaccine (BCRDV, F-strain, 
lentogenic), Izovac B1 Hitchner
®
 (B1 strain, 
lentogenic), Izovac La Sota
®




strain, mesogenic) and Izovac Komarov
® 
(Komarov strain, mesogenic) were 
purchased from veterinary vaccines 
distributor in Kaduna and were used for the 
experiment. The vaccines were stored and 
diluted during use according to the 
manufacturer’s instruction.  
 
Vaccination Schedules 
Chickens in group A were vaccinated 
against ND as follows: Hitchner B1, La Sota 
and Komarov on days 1, 21 and 42 of age, 
respectively as recommended by the 
ABUVTH Poultry clinic; groups B and C 
were vaccinated with clone 30 and F-Strain, 
respectively on day 1 and other vaccines 
remained the same as in group A. group D 
remained as unvaccinated control.
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Newcastle Disease Antigen and Challenge 
Virus  
Newcastle disease vaccine (La Sota strain) 
and NDV Kudu 113 strain were obtained 
from the National Veterinary Research 
Institute (NVRI), Vom, Nigeria. The La 
Sota strain was used as antigen for the HA 
and HI tests, while NDV Kudu 113 strain 
was used as challenge virus. 
 
Serological test for Newcastle disease 
The titre for the NDV antigen was 
determined by haemagglutination (HA) test, 
while the antibody titres in the sera were 
determined by Haemagglutination-inhibition 
(HI) test using the method described by OIE 
(2009). 
 
Challenge of chickens with virulent 
Newcastle disease virus (kudu 113 strain) 
Twenty five chickens from each group were 
inoculated with 0.2 ml of virulent NDV 
Kudu 113 strain suspension containing 10
7
 
EID50 per ml intramuscularly 3 weeks after 
the last vaccination. The Chickens were 
monitored for clinical signs and mortality at 
12 hours intervals post challenge for 14 
days. Postmortem examination was 
conducted on any dead chicken and 
postmortem lesions observed were recorded.   
 
Determination of morbidity, mortality 
and protection rates post challenge 
Clinically sick chickens and mortality 
recorded in different groups after challenge 
with NDV Kudu 113 strain at the end of the 
experiment was calculated as a percentage 
of the initial number of the birds (Guy and 
Garcia, 2008). Also, the protection rate was 
calculated as mortality rate in unvaccinated 
chickens minus the mortality rate in the 
vaccinated chickens divided by the mortality 
rate of the unvaccinated (Babiker et al., 
2008). 
Statistical Analysis 
Results were analyzed by the use of 
statistical package of social sciences (SPSS) 
version 16 using Duncan’s multiple range 
test (DMRT) following analysis of variance 
(ANOVA) to establish the level of 
significance of the immunological response 
of the chickens in the various groups after 
primary and secondary vaccination (Beri, 




The mean ± SEM of haemagglutination 
inhibition (HI) titres of group A, B, C and D 
measured at weeks zero, 3, 6, 9, 10 and 11 
respectively (table 1).  
 
 
TABLE I: Mean antibody titre of chickens (vaccinated with ND vaccines and unvaccinated) 
pre- and post challenge with kudu 113 strain of Newcastle disease virus 
Age (week) Mean antibody titre ± SEM  log2  
        A         B         C          D 
















































a, b, c =Means with the same superscript do not differ significantly 
   level of significance was at p ≤ 0.05 across the rows 
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The maternally-derived antibody (MDA) 
measured on day 1 of the experiment 
showed uniform mean antibody titres with 
no statistical difference. The mean Ab titres 
of the chickens in groups A, B, C and D at 3 
weeks of age were 8.13 ± 0.24, 8.53 ± 0.23, 
7.93 ± 0.34 and 4.16 ± 0.55 respectively. 
There was no significant difference of the 
mean Ab titres among chickens of groups A, 
B and C, while that of chickens in group D 
was significantly lowered at week 3 post 
primary vaccination. At 6 weeks of age, 
there were mean antibody titres of 9.39 ± 
0.13, 8.96 ± 0.25, 6.41 ± 0.37 and 3.50 ± 
0.41 of the chickens in groups A, B, C and 
D, respectively. The higher HI titres were 
found in chicken of groups A and B, which 
differ significantly with the chickens of 
group C and D. The same pattern of HI titres 
differences were observed at week 9.  The 
mean antibody titres of the chickens at 10 
week of age following challenge with the 
virus were 4.68 ± 0.74, 4.00 ± 0.57, 5.20 ± 
0.72 and 5.72 ± 0.43 for groups A, B, C and 
D, respectively. Likewise the mean HI titres 
of the birds among the groups at 11 week of 
age depict similar values to that of week 10. 
Three days post challenge some chickens 
begin to show clinical signs particularly in 
unvaccinated control group. The clinical 
signs manifested were: Somnolence (15/20), 
ruffled feathers (17/20), listlessness (15/20), 
diarrhoea (10/20), reduced feed and water 
intake, depression (13/20), swollen head 
(1/20), coughing and sneezing, rales (4/20), 
sitting on the hock (13/20), recumbence 
(7/20), leg paralysis (4/20), dropped wing 
(3/20), torticollis (5/20), star gazing (3/20) 
and in coordination (2/20). The gross lesions 
observed on dead chickens following post-
mortem examination were congested 
skeletal muscles (10/15), congested liver 
(9/15), congested heart (5/15), congested 
spleen (12/15), congested kidneys (8/15), 
congested lungs (13/15), haemorrhagic 
trachea (15/15), haemorrhages in the 
proventriculus (15/15), haemorrhages in the 
duodenum (12/15) with button ulcers (4/15), 
haemorrhages in the jejunum (10/15) with 
button ulcers (4/15), enlarged and 
haemorrhagic caecal tonsils (12/15), 
haemorrhagic caeca (8/15). The gross 
lesions for the chicken in group C, were 
congested skeletal muscles and 
haemorrhages in the proventriculus, 
duodenum and caecal tonsils. The 
morbidity, mortality and protective rates of 
the treatment and control groups are 
summarised in table II. There were zero 
percent morbidity and mortality rates, while 
100 % protective efficacy was observed in 
chickens of groups A. There was 4 % 
morbidity rate recorded for the chickens in 
group B, while 80 % morbidity rate and 40 
% survival rate were recorded in the 
chickens of the control group. 
 
TABLE II: Morbidity, mortality and protection rates of chickens vaccinated with ND
 vaccines and unvaccinated chickens post challenge with NDV Kudu 113 Strain 






A HB1, La Sota & Komarov 
(live) 
0% (0/25) 0% (0/25) 100% 
B Clone-30, La Sota & 
Komarov (live) 
4% (1/25) 0% (0/25) 100% 
C F-Strain, La Sota & Komarov 
(live) 
4% (1/25) 4% (1/25) 93.3% 
D Control 80% (20/25) 60% (15/25) 40% 
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The protective MDAs observed on day 1 
indicate that the parent stock with which the 
chicks were obtained had adequate Ab titre 
against ND. The increase in the mean NDV 
Ab titres at 3 weeks of age was as a result of 
the first active dose of the vaccination 
administered on day 1. It was clearly shown 
that there was no significant difference 
within the Ab of the chickens in vaccinated 
groups. This could further explain that there 
is no difference in the immunogenicity of 
HB1, Clone-30 and F-strain ND vaccines 
when use as primers. This finding is in 
agreement with the finding of Ibrahim et al. 
(1983) who found no significant difference 
among F-strain, B1 and La Sota strains of 
ND vaccines. The MDA of 4.16 ± 0.55 
observed in the birds of the control group 
may indicate that the titre remains protective 
up to 2 weeks of age which is in consistence 
with the report of Begum et al. (2006) who 
stated that MDA of chicks remains 
protective until 18 days of age. 
However, a significant difference existed 
within the vaccinated groups following 
secondary vaccinations with La Sota and 




 weeks of age 
respectively. The significantly lower Ab 





 weeks of age respectively may be 
due to the higher pathogenicity index of the 
vaccine viral strain (F-strain) which might 
not have produced adequate memory cells as 
compared to the other strains (B1 and 
Clone-30).  
The lower HI titres of group A and B 
chickens after the administration of 
mesogenic strain at 6 weeks of age may be 
related to the virulence nature of the strain 
and the interval between the vaccines, which 
may have interfered with the ongoing Ab 
production, as lower immune response is 
expected when the existing Ab titres is high 
and vice versa (Kouwenhoven, 1993). 
The protective efficiency   (lack of clinical 
disease and mortality) of the vaccines post 
challenge correlated with the Ab production 
at the period of challenge of 8.11 ± 0.34, 
7.80 ± 0.34, and 4.62 ± 0.54 for the chickens 
in groups A, B and C respectively. The 
significant decline of the HI titres of the 





weeks after the challenge at week 9 could be 
attributed to the high Ab titres prior to 
challenge, which was neutralised by the 
challenge ND virus.  
The increase HI titre for the birds in groups 




 weeks post challenge 
can be associated with the low Ab titres at 
the period of challenge. The introduced 
virulent ND virus could have acted as a 
booster for the group C birds while as 
primary vaccinations for the group D 
chickens. Thus may accounted for the 
significant increased mean Ab titre found in 
the birds of group D a week post challenge. 
This finding agreed with the report of Sa’idu 
et al. (2006) who reported an increase in HI 
titres following challenge with NDV kudu 
113 strain in naïve chickens. Therefore, it is 
clear that birds exposed to virulent ND virus 
may respond to decrease or increase Ab 
titres depending on immune status of the 
birds. 
The clinico-pathologic manifestations of the 
disease correlate with the mean Ab level 
across the groups. These were similar to 
those seen in velogenic ND outbreaks 
(McFerran and McCracken, 1988; 
Alexander, 1993; Sa’idu et al., 2006; Sa’idu 
and Abdu, 2008 and Musa et al., 2010).  
Thus, it is clearly showed that there is no 
significant difference among the three 
different vaccines strains of the lentogenic 
origin, with respect to the protective Ab 
titres. This finding agreed with the report of 
Ibrahim et al. (1983) who found no 
difference among F-strain as compared with 
B1 and La Sota strain of ND. However, in 
regards to Ab production, group of chickens 
vaccinated with Hitchner B1 and Clone-30 
produced higher HI titre than that vaccinated 
with F-Strain. 
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Furthermore, among all the vaccines of 
different strains, it was found that after 
primary vaccination, LaSota strain produced 
good humoral immune response. This 
finding is in agreement with Almassy et al. 
(1979) and Westbury (1984) who reported 
that LaSota strain provided superior Ab 
production following vaccination. However, 
the Komarov strain might have contributed 
to the protection against clinical disease and 
mortality from ND.  
 
CONCLUSION 
It was concluded that all the three lentogenic 
vaccines produced satisfactory priming 
effect leading to protection against challenge 
with virulent NDV kudu 113 strain. A good 
immune response and clinical resistance  to 
the disease were observed in group of 
chickens vaccinated with Hitchner B1 and 
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